FindTrial
Sign In

To study effectiveness between Ayurvedic medicine Bharangimool churnavati and Nirgundi ghanavati in the management of Gridhrasi (Sciatica)

A randomized comparative clinical trial to evaluate the efficacy of Bharangimool churnavati and Nirgundi ghanavati in the management of Gridhrasi. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091228
Enrollment
70
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

None listed

Sponsors

PDEAs College of Ayurveda and Research centre Nigdi pradhikaran Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.SLR test positive patient with the help of goniometer. 2.Patients in the age group of 25-60 years ,irrespective of religion,caste,gender and socioeconomic status. 3.Patient with classical signs of Gridhrasi jaanujanghapadam kramat and sakthikshepnigrahanat should be there 4.Radiating pain from kati pradesh (lower back) to paad ( foot )should be there . Radiating pain along the course and distribution of sciatic nerve 5.Associated symptoms are- Patients having two or more following symptoms - katishool (lower back pain) spand (throbbing /pulsating) toda (pricking sensation ) aruchi ( anorexia) Gourav(heaviness) paadshool (leg pain )

Exclusion criteria

Exclusion criteria: 1.Patients having congenital anomalies with lumbosacral spine kyphosis, scoliosis, lordosis. 2.Known case of Spondylolisthesis, sacroiliac arthritis. 3.Known case of uncontrolled diabetes mellitus , deep vein thrombosis. 4.Pregnant and lactating mothers. 5.Patients with paraplegia of lower limb. 6.Fracture of spinal bones or in lower extremity bones. 7.Known case of Infective disorders tuberculosis of Spine, osteomyelitis of spinal bone. 8.Patients with deep wounds penetrating till sciatic nerve. 9.Patients having any major chronic/acute systemic /surgical pathology like malignancies. 10.Patients having allergy to any content of drugs.

Design outcomes

Primary

MeasureTime frame
1.To compare the efficacy Of Bharangimool churnavati and Nirgundi Ghanvati In relieving pain given for 21 days in management of Gridhrasi Timepoint: 21 Days with follow up on 8th,15th,22nd day—

Secondary

MeasureTime frame
1.To compare the efficacy Of Bharangimool churnavati and Nirgundi Ghanvati for relieving other symptoms given for 21 days in management of Gridhrasi . 2.To observe and compare the adverse effects in two groups within 21 days Timepoint: 21 Days with follow up on 8th,15th,22nd day—

Countries

India

Contacts

Public ContactDr Rutuja Chandrakant Solunke

PDEAs college of ayurved and Research centre,Nigdi,pune 411044

taksaleabhishek@gmail.com9011061293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026